These random molecules were fed a collection of three-base-long RNAs, each linked to a chemical tag. The idea was that if a molecule is capable of ligating one of these short RNA fragments to itself, ...
There is a history of studying relaxin in cardiovascular settings—Novartis started a phase 3 heart failure trial of a recombinant relaxin-2 peptide in 2013—but preclinical evidence of the molecule’s ...
TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...
Syringes are probably among the top three concerns that I hear from the business community,” the CEO of the local chamber of ...
The developers behind Black Mesa return with a retro-flavoured co-op shooter that thumbs its nose at the bloated complexity of modern online games ...
Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...
Dr. Maarten Dewilde, an associate professor at KU Leuven, sat down with Technology Networks to discuss molecular engineering ...
Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...
BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.
The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?
To boost morning energy, there are a number of low-effort evening habits you can start implementing–even if you don't get enough sleep every night.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results